Expression of protein gene product 9.5 and Tyrosine hydroxylase in childhood small round cell tumors

Clinical Cancer Research

Volumn 6, Issue 2, 2000, Pages 551-558

  Wang, Yinglin ^a,b   Einhorn, Peggy ^a   Triche, Timothy J ^b   Seeger, Robert C ^a,b   Reynolds, C Patrick ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; RNA; TYROSINE 3 MONOOXYGENASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; EWING SARCOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LYMPHOMA; NEUROBLASTOMA; NEUROECTODERM TUMOR; PRIORITY JOURNAL; RHABDOMYOSARCOMA; RNA ANALYSIS;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; LYMPHOMA; NEOPLASM STAGING; NEUROBLASTOMA; NEUROECTODERMAL TUMORS, PRIMITIVE; RHABDOMYOSARCOMA; THIOLESTER HYDROLASES; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TYROSINE 3-MONOOXYGENASE; UBIQUITIN THIOLESTERASE;

EID: 0033964061     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Triche, T. J. Pathology and molecular diagnosis of pediatric malignancies. In: P. A. Pizzo and D. G. Poplack (eds.), Principles and Practice of Pediatric Oncology, pp. 141-185. Philadelphia: Lippincott-Raven, 1997.
2. Roessner, A., Voss, B., Rauterberg, J., Immenkamp, M., and Grundmann, E. Biologic characterization of human bone tumors. I. Ewing's sarcoma. A comparative electron and immunofluorescence microscopic study. J. Cancer Res. Clin. Oncol., 104: 171-180, 1982.
3. Kojima, M. Cytological characterization and histogenesis of Ewing's sarcoma. Acta Pathol. Jpn., 26: 167-190, 1976.
4. Dickman, P. S., Liotta, L. A., and Triche, T. J. Ewing's sarcoma. Characterization in established cultures and evidence of its histogenesis. Lab. Investig., 47: 375-382, 1982.
5. Aurias, A., Rimbaut, C., Buffe, D., Dubousset, J., and Mazabraud, A. Translocation of chromosome 22 in Ewing's sarcoma [in French], C. R. Seances Acad. Sci. Ser. III Sci. Vie, 296: 1105-1107, 1983.
6. Gorman, P. A., Malone, M., Pritchard, J., and Sheer, D. Cytogenetic analysis of primitive neuroectodermal tumors. Absence of the t(11;22) in two of three cases and a review of the literature. Cancer Genet. Cytogenet., 51: 13-22, 1991.
7. Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., and Rouleau, G. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature (Lond.), 359: 162-165, 1992.
8. Taylor, C., Patel, K., Jones, T., Kiely, F., De Stavola, B. L., and Sheer, D. Diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumour based on the detection of t(11;22) using fluorescence in situ hybridisation. Br. J. Cancer, 67: 128-133, 1993.
9. Sorensen, P. H., Liu, X. F., Delattre, O., Rowland, J. M., Biggs, C. A., Thomas, G., and Triche, T. J. Reverse transcriptase PCR amplification of EWS/FLI-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermal tumors of childhood. Diagn. Mol. Pathol., 2: 147-157, 1993.
10. Caillaud, J. M., Benjelloun, S., Bosq, J., Braham, K., and Lipinski, M. HNK-1-defined antigen detected in paraffin-embedded neuroectoderm tumors and those derived from cells of the amine precursor uptake and decarboxylation system. Cancer Res., 44: 4432-4439, 1984.
11. Jaffe, R., Santamaria, M., Yunis, E. J., Tannery, N. H., Agostini, R. M. J., Medina, J., and Goodman, M. The neuroectodermal tumor of bone. Am. J. Surg. Pathol., 8: 885-898, 1984.
12. Cavazzana, A. O., Miser, J. S., Jefferson, J., and Triche, T. J. Experimental evidence for a neural origin of Ewing's sarcoma of bone. Am. J. Pathol., 127: 507-518, 1987.
13. Ambros, I. M., Ambros, P. F., Strehl, S., Kovar, H., Gadner, H., and Salzer-Kuntschik, M. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer (Phila.), 67: 1886-1893, 1991.
14. Jackson, P., and Thompson, R. J. The demonstration of new human brain-specific proteins by high-resolution two-dimensional polyacrylamide gel electrophoresis. J. Neurol. Sci., 49: 429-438, 1981.
15. Doran, J. F., Jackson, P., Kynoch, P. A., and Thompson, R. J. Isolation of PGP 9.5, a new human neurone-specific protein detected by high-resolution two-dimensional electrophoresis. J. Neurochem., 40: 1542-1547, 1983.
16. Rode, J., Dhillon, A. P., Doran, J. F., Jackson, P., and Thompson, R. J. PGP 9.5, a new marker for human neuroendocrine tumours. Histopathology, 9: 147-158, 1985.
17. Wilkinson, K. D., Lee, K. M., Deshpande, S., Duerksen-Hughes, P., Boss, J. M., and Pohl, J. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science (Washington DC), 246: 670-673, 1989.
18. Nagatsu, T. The human tyrosine hydroxylase gene. Cell. Mol. Neurobiol., 9: 313-321, 1989.
19. Reynolds, C. P., and Seeger, R. C. Neuroblastoma. In: C. M. Haskell (ed.), Cancer Treatment, pp. 860-871. Philadelphia: W. B. Sanders, 1995.
20. Reynolds, C. P., Biedler, J. L., Spengler, B. A., Reynolds, D. A., Ross, R. A., Frenkel, E. P., and Smith, R. G. Characterization of human neuroblastoma cell lines established before and after therapy. J. Natl. Cancer Inst., 76: 375-387, 1986.
21. Reynolds, C. P., Smith, R. G., and Frenkel, E. P. The diagnostic dilemma of the "small round cell neoplasm": catecholamine fluorescence and tissue culture morphology as markers for neuroblastoma. Cancer (Phila.), 48: 2088-2094, 1981.
22. McKeon, C., Thiele, C. J., Ross, R. A., Kwan, M., Triche, T. J., Miser, J., and Israel, M. A. Indistinguishable patterns of protooncogene expression in two distinct but closely related tumors: Ewing's sarcoma and neuroepithelioma. Cancer Res., 48: 4307-4311, 1988.
23. Schlesinger, H. R., Gerson, J. M., Moorhead, P. S., Maguire, H., and Hummeler, K. Establishment and characterization of human neuroblastoma cell lines. Cancer Res., 36: 3094-3100, 1976.
24. Schlesinger, H. R., Rorke, L., Jamieson, R., and Hummeler, K. Neuronal properties of neuroectodermal tumors in vitro. Cancer Res., 41: 2573-2575, 1981.
25. Seeger, R. C., Danon, Y. L., Rayner, S. A., and Hoover, F. Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma, and teratorna cells with a monoclonal antibody. J. Immunol., 128: 983-989, 1982.
26. Wada, R. K., Seeger, R. C., Brodeur, G. M., Slamon, D., Rayner, S. A., Tomayko, M., and Reynolds, C. P. Characterization of human neuroblastoma cell lines that lack N-myc gene amplification. Prog. Clin. Biol. Res., 271: 57-69, 1988.
27. Schmechel, D., Marangos, P. J., and Brightman, M. Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature (Lond.), 276: 834-836, 1978.
28. Helson, L., Nisselbaum, J., Helson, C., Majeranowski, A., and Johnson, G. A. Biological markers in neuroblastoma and other pediatric neoplasias. In: W. Davis, K. R. Harrap, and G. Stathopoulos (eds.), Human Cancer. Its Characterization and Treatment, pp. 86-94. Princeton: Excerpta Medica, 1980.
29. Reynolds, C. P., Tomayko, M. M., Donner, L., Helson, L., Seeger, R. C., Triche, T. J., and Brodeur, G. M. Biological classification of cell lines derived from human extra-cranial neural tumors. Prog. Clin. Biol. Res., 271: 291-306, 1988.
30. Biedler, J. L., Helson, L., and Spengler, B. A. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res., 33: 2643-2652, 1973.
31. Wada, R. K., Seeger, R. C., Brodeur, G. M., Einhorn, P., Rayner, S. A., Tomayko, M. M., and Reynolds, C. P. Human neuroblastoma cell lines that express N-myc without gene amplification. Cancer (Phila.), 72: 3346-3354, 1993.
32. Brodeur, G. M., Sekhon, G., and Goldstein, M. N. Chromosomal aberrations in human neuroblastomas. Cancer (Phila.), 40: 2256-2263, 1977.
33. Tumilowicz, J. J., Nichols, W. W., Cholon, J. J., and Greene, A. E. Definition of a continuous human cell line derived from neuroblastoma. Cancer Res., 30: 2110-2118, 1970.
34. Sorensen, P. H., Wu, J. K., Berean, K. W., Lim, J. F., Donn, W., Frierson, H. F., Reynolds, C. P., Lopez-Terrada, D., and Triche, T. J. Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma. Proc. Natl. Acad. Sci. USA, 93: 1038-1043, 1996.
35. Potluri, V. R., Gilbert, F., Helsen, C., and Helson, L. Primitive neuroectodermal tumor cell lines: chromosomal analysis of five cases. Cancer Genet. Cytogenet., 24: 75-86, 1987.
36. Whang-Peng, J., Triche, T. J., Knutsen, T., Miser, J., Kao-Shan, S., Tsai, S., and Israel, M. A. Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet. Cytogenet., 21: 185-208, 1986.
37. Bloom, E. T. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture. Cancer Res., 32: 960-967, 1972.
38. McAllister, R. M., Melnyk, J., Finkelstein, J. Z., Adams, E. C., Jr., and Gardner, M. B. Cultivation in vitro of cells derived from a human rhabdomyosarcoma. Cancer (Phila.), 24: 520-526, 1969.
39. Collins, S. J., Gallo, R. C., and Gallagher, R. E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature (Lond.), 270: 347-349, 1977.
40. Morikawa, S., Tatsumi, E., Baba, M., Harada, T., and Yasuhira, K. Two E-rosette-forming lymphoid cell lines. Int. J. Cancer, 21: 166-170, 1978.
41. Lozzio, C. B., and Lozzio, B. B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood, 45: 321-334, 1975.
42. Minowada, J., Onuma, T., and Moore, G. E. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J. Natl. Cancer Inst., 49: 891-895, 1972.
43. Hiraki, S., Miyoshi, I., Kubonishi, I., Matsuda, Y., Nakayama, T., Kishimoto, H., and Masuji, H. Human leukemic "null" cell line (NALL-1). Cancer (Phila.), 40: 2131-2135, 1977.
44. Han, T., Dadey, B., and Minowada, J. Cultured human leukemic non-T/non-B lymphoblasts and their stimulating capacity in "one-way" mixed lymphocyte reaction: suggestive evidence for early T-cell or B-cell precursors. Cancer (Phila.), 44: 136-140, 1979.
45. Smith, R. G., Dev, V. G., and Shannon, W. A., Jr. Characterization of a novel human pre-B leukemia cell line. J. Immunol., 126: 596-602, 1981.
46. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
47. Day, I. N., and Thompson, R. J. Molecular cloning of cDNA coding for human PGP 9.5 protein. A novel cytoplasmic marker for neurones and neuroendocrine cells. FEBS Lett., 210: 157-160, 1987.
48. Grima, B., Lamouroux, A., Boni, C., Julien, J. F., Javoy-Agid, F., and Mallet, J. A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics. Nature (Lond.), 326: 707-711, 1987.
49. Marangos, P. J., Goodwin, F. K., Parma, A., Lauter, C., and Trams, E. Neuron specific protein (NSP) in neuroblastoma cells: relation to differentiation. Brain Res., 145: 49-58, 1978.
50. Carter, R. L., al-Sams, S. Z., Corbett, R. P., and Clinton, S. A comparative study of immunohistochemical staining for neuron-specific enolase, protein gene product 9.5 and S-100 protein in neuroblastoma. Ewing's sarcoma and other round cell tumours in children. Histopathology, 16: 461-467, 1990.
51. Sorensen, P. H., Shimada, H., Liu, X. F., Lim, J. F., Thomas, G., and Triche, T. J. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene. Cancer Res., 55: 1385-1392, 1995.
52. Coker, G. T., III, Studelska, D., Harmon, S., Burke, W., and O'Malley, K. L. Analysis of tyrosine hydroxylase and insulin transcripts in human neuroendocrine tissues. Mol. Brain Res., 8: 93-98, 1990.
53. Seeger, R. C., Wada, R., Brodeur, G. M., Moss, T. J., Bjork, R. L., Sousa, L., and Slamon, D. J. Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene. Prog. Clin. Biol. Res., 271: 41-49, 1988.
54. Tomayko, M. M., Triche, T. J., Newburgh, R. W., and Reynolds, C. P. Induction of catecholamine fluorescence in human neuroblastoma cell lines transplanted into nude mice. Prog. Clin. Biol. Res., 271: 307-316, 1988.
55. Yee, D., Favoni, R. E., Lebovic, G. S., Lombana, P., Powell, D. R., Reynolds, C. P., and Rosen, N. Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor. J. Clin. Investig., 86: 1806-1814, 1990.
56. Moss, T. J., and Sanders, D. G. Detection of neuroblastoma cells in blood. J. Clin. Oncol., 8: 736-740, 1990.
57. Moss, T. J., Reynolds, C. P., Sather, H. N., Romansky, S. G., Hammond, G., and Seeger, R. C. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N. Engl. J. Med., 324: 219-226, 1991.
58. Naito, H., Kuzumaki, N., Uchino, J., Kobayashi, R., Shikano, T., Ishikawa, Y., and Matsumoto, S. Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur. J. Cancer, 27: 762-765, 1991.
59. Mattano, L. A., Jr., Moss, T. J., and Emerson, S. G. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res., 52; 4701-4705, 1992.
60. Burchill, S. A., Bradbury, F. M., Smith, B., Lewis, I. J., and Selby, P. Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Int. J. Cancer, 57: 671-675, 1994.
61. Ghossein, R. A., Bhattacharya, S., and Rosai, J. Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin. Cancer Res., 5: 1950-1960, 1999.
62. Peter, M., Magdelenat, H., Michon, J., Melot, T., Oberlin, O., Zucker, J. M., Thomas, G., and Delattre, O. Sensitive detection of occult Ewing's cells by the reverse transcriptase-polymerase chain reaction. Br. J. Cancer, 72: 96-100, 1995.